ストックスクリーナーアプリを入手
1.30
3.70%
-0.05
前日終値:
$1.35
開ける：
$1.38
24時間の取引高:
1.06M
Relative Volume:
0.61
時価総額：
$483.94M
収益：
$106.34M
当期純損益:
$-74.66M
株価収益率:
-1.3684
EPS:
-0.95
ネットキャッシュフロー:
$-46.12M
1週間 パフォーマンス:
-7.80%
1か月 パフォーマンス:
-30.85%
6か月 パフォーマンス:
-32.99%
1年 パフォーマンス:
-45.83%
1日の値動き範囲:
$1.30
$1.39
1週間の範囲:
$1.30
$1.51
52週間の値動き範囲:
$1.1725
$3.04
Standard Biotools Inc Stock (LAB) Company Profile
名前
Standard Biotools Inc
セクター
電話
(650) 266-6000
住所
2 TOWER PLACE, SOUTH SAN FRANCISCO
LAB を他の銘柄と比較する
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
LAB
Standard Biotools Inc
|
1.30 | 483.94M | 106.34M | -74.66M | -46.12M | -0.95 |
|
ABT
Abbott Laboratories
|
134.92 | 234.01B | 41.95B | 13.40B | 6.49B | 7.65 |
|
BSX
Boston Scientific Corp
|
104.49 | 154.20B | 16.75B | 1.85B | 2.37B | 1.25 |
|
SYK
Stryker Corp
|
382.78 | 146.06B | 22.60B | 2.99B | 3.49B | 7.76 |
|
MDT
Medtronic Plc
|
89.94 | 115.42B | 33.20B | 4.26B | 5.47B | 3.29 |
|
EW
Edwards Lifesciences Corp
|
73.30 | 43.23B | 5.72B | 4.17B | 490.10M | 6.97 |
Standard Biotools Inc Stock (LAB) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2024-04-16 | 開始されました | TD Cowen | Buy |
| 2024-04-04 | 開始されました | Jefferies | Buy |
| 2023-07-12 | 開始されました | KeyBanc Capital Markets | Overweight |
Standard Biotools Inc (LAB) 最新ニュース
Market Cool On Standard BioTools Inc.'s (NASDAQ:LAB) Revenues Pushing Shares 28% Lower - Simply Wall St
Standard BioTools (LAB) to Release Earnings on Wednesday - MarketBeat
Standard BioTools (NASDAQ:LAB) Stock Price Up 7.1%Here's What Happened - MarketBeat
Sumitomo Mitsui Trust Group Inc. Sells 2,960,169 Shares of Standard BioTools Inc. (NASDAQ:LAB) - MarketBeat
Standard BioTools (NASDAQ:LAB) Hits New 52-Week LowTime to Sell? - MarketBeat
Taking a look at what insiders are doing to gauge the Standard BioTools Inc (LAB)’s direction - Knox Daily
Fluidigm stock hits 52-week low at $1.21 amid market challenges - MSN
Standard BioTools Schedules Fourth Quarter and Full Year 2024 Earnings Conference Call on February 26, 2025 - GlobeNewswire
Standard BioTools Sets Date for Crucial Year-End Financial Results Reveal - StockTitan
Standard BioTools Inc (LAB)’s Day in Review: Closing at 1.38, Down by -2.82 - The Dwinnex
Is Standard BioTools (NASDAQ:LAB) Using Debt Sensibly? - Simply Wall St
Standard BioTools Inc (NASDAQ: LAB): Can A Stock Be -21.71% Lower Year-To-Date And Still Be A Loser? - Marketing Sentinel
LAB’s 52-Week Rollercoaster: From $1.21 to $3.04 – What’s Next for Investors? - The InvestChronicle
Standard BioTools Inc [LAB] Records 200-Day SMA of $1.9928 - Knox Daily
SG Americas Securities LLC Acquires 34,670 Shares of Standard BioTools Inc. (NASDAQ:LAB) - Defense World
LAB’s latest rating updates from top analysts. - Knox Daily
Investing in Standard BioTools Inc (LAB) might be a great opportunity, but the stock is a bit undervalued - US Post News
Financial Metrics Unveiled: Standard BioTools Inc (LAB)’s Key Ratios in the Spotlight - The Dwinnex
Fluidigm Corporation : SINGuLAR™ Analysis Toolset 2.1 -January 29, 2014 at 06:22 pm EST - Marketscreener.com
Sequencing Reagents Market Trends Analysis Report 2025-2030, with Illumina, QIAGEN, BGI, PacBio, Oxford Nanopore Technologies, Agilent Technologies, Standard BioTools, Takara Bio & Meridian Bioscience - Yahoo Finance
Standard BioTools (NASDAQ:LAB) Stock Price Down 5.8%What's Next? - MarketBeat
Standard BioTools Inc. (NASDAQ:LAB) Shares Purchased by JPMorgan Chase & Co. - Defense World
Genomics Market to Grow by USD 5.21 Billion (2024-2028), Boosted by Rising Investments in R&D, with AI Impacting Market TrendsTechnavio - Yahoo Finance
Genomics Market to Grow by USD 5.21 Billion (2024-2028), Boosted by Rising Investments in R&D, with AI Driving Market TransformationTechnavio - Yahoo Finance
Standard BioTools (NASDAQ:LAB) Stock Price Down 8.5%Should You Sell? - MarketBeat
Things To Consider Before You Buy Standard BioTools Inc (NASDAQ: LAB) - Stocks Register
Standard BioTools (NASDAQ:LAB) Shares Gap DownHere's Why - MarketBeat
Appian, Bitfarms, Standard BioTools, and More Stocks See Action From Activist Investors - MSN
Now Is The Time To Build A Position In Standard BioTools Inc (NASDAQ:LAB) - Marketing Sentinel
Standard BioTools (NASDAQ:LAB) Trading Down 5.8%Here's What Happened - MarketBeat
Standard BioTools stock soars on Q4 revenue beat By Investing.com - Investing.com South Africa
Standard BioTools stock soars on Q4 revenue beat - Investing.com India
Standard BioTools (NASDAQ:LAB) Shares Gap UpWhat's Next? - MarketBeat
Standard BioTools stock soars on upbeat preliminary 4Q revenue By Investing.com - Investing.com Canada
Intra-Cellular Therapies, Standard BioTools, SI-BONE And Other Big Stocks Moving Higher On Monday - Benzinga
Standard BioTools Inc. Provides Earnings Guidance for the Fourth Quarter and Full Year 2024 - Marketscreener.com
Standard BioTools Reports 2024 Revenue Achievements and Plans - TipRanks
Standard BioTools Announces Preliminary Fourth Quarter and Full Year 2024 Revenue - The Manila Times
In the wake of Standard BioTools Inc.'s (NASDAQ:LAB) latest US$52m market cap drop, institutional owners may be forced to take severe actions - Simply Wall St
Standard BioTools Hits Top-End Revenue Target of $174M, Slashes Operating Costs in 2024 - StockTitan
Standard BioTools announces CCO Jeremy Davis's departure By Investing.com - Investing.com Canada
Standard BioTools announces CCO Jeremy Davis's departure - Investing.com India
Standard BioTools Announces CCO Jeremy Davis’s Departure - TipRanks
Standard Biotools Inc (LAB) 財務データ
収益
当期純利益
現金流量
EPS
1.16%
0.10%
大文字化:
|
ボリューム (24 時間):